These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 25501928)

  • 1. Mechanistic insights into xanthine oxidoreductase from development studies of candidate drugs to treat hyperuricemia and gout.
    Nishino T; Okamoto K
    J Biol Inorg Chem; 2015 Mar; 20(2):195-207. PubMed ID: 25501928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical nature and reaction mechanisms of the molybdenum cofactor of xanthine oxidoreductase.
    Okamoto K; Kusano T; Nishino T
    Curr Pharm Des; 2013; 19(14):2606-14. PubMed ID: 23116398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the Inhibition Mechanism of Xanthine Oxidoreductase by Oxipurinol: A Computational Study.
    Maghsoud Y; Dong C; Cisneros GA
    J Chem Inf Model; 2023 Jul; 63(13):4190-4206. PubMed ID: 37319436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperuricemia-Related Diseases and Xanthine Oxidoreductase (XOR) Inhibitors: An Overview.
    Chen C; Lü JM; Yao Q
    Med Sci Monit; 2016 Jul; 22():2501-12. PubMed ID: 27423335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminating Susceptibility of Xanthine Oxidoreductase Family to Metals.
    Steunou AS; Babot M; Durand A; Bourbon ML; Liotenberg S; Miotello G; Armengaud J; Ouchane S
    Microbiol Spectr; 2023 Aug; 11(4):e0481422. PubMed ID: 37458582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xanthine oxidoreductase and its inhibitors: relevance for gout.
    Day RO; Kamel B; Kannangara DR; Williams KM; Graham GG
    Clin Sci (Lond); 2016 Dec; 130(23):2167-2180. PubMed ID: 27798228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vibrational Probes of Molybdenum Cofactor-Protein Interactions in Xanthine Dehydrogenase.
    Dong C; Yang J; Reschke S; Leimkühler S; Kirk ML
    Inorg Chem; 2017 Jun; 56(12):6830-6837. PubMed ID: 28590138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a Rhodobacter capsulatus L-cysteine desulfurase that sulfurates the molybdenum cofactor when bound to XdhC and before its insertion into xanthine dehydrogenase.
    Neumann M; Stöcklein W; Walburger A; Magalon A; Leimkühler S
    Biochemistry; 2007 Aug; 46(33):9586-95. PubMed ID: 17649978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protonation and Sulfido versus Oxo Ligation Changes at the Molybdenum Cofactor in Xanthine Dehydrogenase (XDH) Variants Studied by X-ray Absorption Spectroscopy.
    Reschke S; Mebs S; Sigfridsson-Clauss KG; Kositzki R; Leimkühler S; Haumann M
    Inorg Chem; 2017 Feb; 56(4):2165-2176. PubMed ID: 28170236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Structure and mechanism of molybdenum hydroxylase].
    Okamoto K; Nishino T
    Seikagaku; 2008 Jun; 80(6):531-9. PubMed ID: 18634428
    [No Abstract]   [Full Text] [Related]  

  • 11. Cell biology of molybdenum in plants and humans.
    Mendel RR; Kruse T
    Biochim Biophys Acta; 2012 Sep; 1823(9):1568-79. PubMed ID: 22370186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations associated with functional disorder of xanthine oxidoreductase and hereditary xanthinuria in humans.
    Ichida K; Amaya Y; Okamoto K; Nishino T
    Int J Mol Sci; 2012 Nov; 13(11):15475-95. PubMed ID: 23203137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a molybdopterin-containing molybdenum cofactor in xanthine dehydrogenase from Pseudomonas aeruginosa.
    Johnson JL; Chaudhury M; Rajagopalan KV
    Biofactors; 1991 Jun; 3(2):103-7. PubMed ID: 1654922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The double faced role of xanthine oxidoreductase in cancer.
    Chen MM; Meng LH
    Acta Pharmacol Sin; 2022 Jul; 43(7):1623-1632. PubMed ID: 34811515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Oxidative Stress in Hyperuricemia and Xanthine Oxidoreductase (XOR) Inhibitors.
    Liu N; Xu H; Sun Q; Yu X; Chen W; Wei H; Jiang J; Xu Y; Lu W
    Oxid Med Cell Longev; 2021; 2021():1470380. PubMed ID: 33854690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel xanthine oxidoreductase inhibitor for hyperuricemia treatment with high efficacy and safety profile.
    Li X; Chen D; Qi C; Yang Y; Guo K; Ma C; Tian J; Li J; Zhang L; Wang B; Xiao Z; Ye F
    Biomed Pharmacother; 2024 Sep; 178():117223. PubMed ID: 39094541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell biology of molybdenum in plants.
    Mendel RR
    Plant Cell Rep; 2011 Oct; 30(10):1787-97. PubMed ID: 21660547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhodobacter capsulatus XdhC is involved in molybdenum cofactor binding and insertion into xanthine dehydrogenase.
    Neumann M; Schulte M; Jünemann N; Stöcklein W; Leimkühler S
    J Biol Chem; 2006 Jun; 281(23):15701-8. PubMed ID: 16597619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibitors of xanthine oxidoreductase].
    Okamoto K
    Nihon Rinsho; 2008 Apr; 66(4):748-53. PubMed ID: 18409526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of xanthine dehydrogenase from the anaerobic bacterium Veillonella atypica and identification of a molybdopterin-cytosine-dinucleotide-containing molybdenum cofactor.
    Gremer L; Meyer O
    Eur J Biochem; 1996 Jun; 238(3):862-6. PubMed ID: 8706691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.